NEW YORK, July 18, 2017 /PRNewswire/ -- Faruqi & Faruqi,
LLP, a leading national securities law firm, is investigating potential securities fraud at AngioDynamics, Inc. ("AngioDynamics"
or the "Company") (NASDAQ: ANGO).
The investigation focuses on whether the Company and its executives violated federal securities laws. Specifically,
after market on July 17, 2017, the Company filed a Form 8-K with the Securities and Exchange
Commission disclosing, among other things, that its former independent registered public accounting firm has "determined that
there was a material weakness in the Company's internal control over financial reporting as of May 31,
2016 because the Company did not design and maintain effective internal controls over the accounting for the annual
goodwill impairment test."
On this news, the Company's share price declined, causing harm to investors.
If you invested in AngioDynamics stock or options and would like to discuss your legal rights, click here: www.faruqilaw.com/ANGO.
There is no cost or obligation to you.
You can also contact us by calling Richard Gonnello toll free at
877-247-4292 or at 212-983-9330 or by sending an e-mail to rgonnello@faruqilaw.com.
CONTACT:
FARUQI & FARUQI, LLP
685 Third Avenue, 26th Floor
New York, NY 10017
Attn: Richard Gonnello, Esq.
rgonnello@faruqilaw.com
Telephone: (877) 247-4292 or (212) 983-9330
Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All
communications will be treated in a confidential manner.
View original content with multimedia:http://www.prnewswire.com/news-releases/angiodynamics-investor-alert-faruqi--faruqi-llp-encourages-investors-who-suffered-losses-exceeding-50000-investing-in-angiodynamics-inc-to-contact-the-firm-300490141.html
SOURCE Faruqi & Faruqi, LLP